Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent prescription substance use disorder.
Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.
Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.
Requires warning labels on addictive feature platforms which provide features such as addictive feeds, autoplay, infinite scroll, like counts, and/or push notifications; relates to the effectiveness of certain provisions of law relating thereto.
Requires warning labels on addictive feature platforms which provide features such as addictive feeds, autoplay, infinite scroll, like counts, and/or push notifications; relates to the effectiveness of certain provisions of law relating thereto.
Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.